BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 12436240)

  • 1. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
    Ogino S; Wilson RB
    Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations.
    Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C
    Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
    Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
    Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
    Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
    Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk assessment in carrier testing for spinal muscular atrophy.
    Ogino S; Leonard DG; Rennert H; Ewens WJ; Wilson RB
    Am J Med Genet; 2002 Jul; 110(4):301-7. PubMed ID: 12116201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening and cascade testing for carriers of SMA.
    Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D
    Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy genetic testing experience at an academic medical center.
    Ogino S; Leonard DG; Rennert H; Wilson RB
    J Mol Diagn; 2002 Feb; 4(1):53-8. PubMed ID: 11826188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
    Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
    Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.
    Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L
    Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
    Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
    Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations.
    Clermont O; Burlet P; Benit P; Chanterau D; Saugier-Veber P; Munnich A; Cusin V
    Hum Mutat; 2004 Nov; 24(5):417-27. PubMed ID: 15459957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
    Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
    Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of deletional damage in SMN1, SMN2, and NAIP genes in patients with spinal muscular atrophy in the northwestern region of Russia].
    Glotov AS; Kiselev AV; Ivashchenko TE; Baranov VS
    Genetika; 2001 Aug; 37(8):1156-9. PubMed ID: 11642117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of SMN1 and SMN2 copy number using TaqMan technology.
    Anhuf D; Eggermann T; Rudnik-Schöneborn S; Zerres K
    Hum Mutat; 2003 Jul; 22(1):74-8. PubMed ID: 12815596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.
    Bouhouche A; Benomar A; Birouk N; Bouslam N; Ouazzani R; Yahyaoui M; Chkili T
    J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.
    Cuscó I; Barceló MJ; Baiget M; Tizzano EF
    Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.